Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?

NCT ID: NCT04168047

Last Updated: 2020-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-31

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with severity and altered quality of life. Sleeping troubles are most frequent in IBS population. Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could decrease pain threshold.

Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS patients with insomnia probably have lower visceral pain threshold.

The objective is to assess pain threshold during a barostat procedure in in IBS patients with or without insomnia in comparison with healthy volunteers or patients with insomnia.

If the hypothesis are confirmed, insomnia should be look at in IBS patients and its treatments could improve visceral hypersensitivity and IBS symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy volunteers

Group Type OTHER

Barostat procedure

Intervention Type PROCEDURE

Pressure threshold will be measured during the barostat procedure

Anxiety and Depression Evaluation

Intervention Type OTHER

Anxiety and Depression will be measured using HAD anxiety and depression scale

Assessment of sleep quality

Intervention Type OTHER

Sleep quality will be measured using Pittsburg sleep quality index

Patients with insomnia

Group Type OTHER

Barostat procedure

Intervention Type PROCEDURE

Pressure threshold will be measured during the barostat procedure

Anxiety and Depression Evaluation

Intervention Type OTHER

Anxiety and Depression will be measured using HAD anxiety and depression scale

Assessment of sleep quality

Intervention Type OTHER

Sleep quality will be measured using Pittsburg sleep quality index

Patients with irritable bowel syndrome

Group Type OTHER

Barostat procedure

Intervention Type PROCEDURE

Pressure threshold will be measured during the barostat procedure

Anxiety and Depression Evaluation

Intervention Type OTHER

Anxiety and Depression will be measured using HAD anxiety and depression scale

Assessment of sleep quality

Intervention Type OTHER

Sleep quality will be measured using Pittsburg sleep quality index

Patients with irritable bowel syndrome and insomnia

Group Type EXPERIMENTAL

Barostat procedure

Intervention Type PROCEDURE

Pressure threshold will be measured during the barostat procedure

Anxiety and Depression Evaluation

Intervention Type OTHER

Anxiety and Depression will be measured using HAD anxiety and depression scale

Assessment of sleep quality

Intervention Type OTHER

Sleep quality will be measured using Pittsburg sleep quality index

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Barostat procedure

Pressure threshold will be measured during the barostat procedure

Intervention Type PROCEDURE

Anxiety and Depression Evaluation

Anxiety and Depression will be measured using HAD anxiety and depression scale

Intervention Type OTHER

Assessment of sleep quality

Sleep quality will be measured using Pittsburg sleep quality index

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy volunteers

\- Person aged over 18 years with no IBS and no Insomnia
2. Patients with insomnia

\- Patient aged over 18 years with no IBS and no Insomnia
3. Patients with IBS

\- Patient aged over 18 years with IBS
4. patients with insomnia and IBS - Patient aged over 18 years with IBS

Exclusion Criteria

* Active chronic organic disease
* Endometriosis
* Opioids consumption
* Change in chronic treatment in the last 30 days
* Hypersensitivity to Normacol
* Patient with blood dyscrasia disorder known or identified, anticoagulant or antiplatelet treatments
* Rectal pathology
* Intestinal occlusion
* Severe renal failure
* Sodium retention
* Anal pathology (anal fissure, hemorrhoidal thrombosis)
* Person with administrative or judicial decision or under legal protection measure
* Patient participating in another trial in the last 30 days
* Pregnant or breastfeeding women
* Impossibility to keep fasting for 12 hours
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Rouen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chloé MECHIOR, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Rouen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rouen University Hospital

Rouen, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chloé MECHIOR, MD

Role: CONTACT

+3323288 ext. 8990

Julien BLOT

Role: CONTACT

+3323288 ext. 8265

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chloé MELCHIOR, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016/381/HP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.